Document is current
Any future updates will be listed below
-
Authors
Garcia-Donas, Jesus https://orcid.org/0000-0001-7731-3601
Hurtado, Alicia
Garrigos, Laia
Santaballa, Ana
Redondo, Andres
Vidal, Laura
Lainez, Nuria
Guerra, Eva
Rodriguez, Victor
Cueva, Juan
Bover, Isabel
Palacio, Isabel
Rubio, Maria Jesus
Prieto, Mario
Lopez-Guerrero, Jose Antonio
Rodriguez-Moreno, Juan Francisco
Garcia-Casado, Zaida
Garcia-Martinez, Elena
Taus, Alvaro
de Castro, Ignacio Pérez
Navarro, Paloma
Grande, Enrique
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01584297 at ClinicalTrials.govDocuments that mention this clinical trial
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03
https://doi.org/10.1007/s12094-023-03085-w
-
Funding
Funding for this research was provided by:
Ministerio de Sanidad, Consumo y Bienestar Social (EC11-178)
- License Information
-
More Information
Article History
Received: 31 October 2022
Accepted: 10 January 2023
First Online: 28 January 2023
Declarations
:
: All authors declared no conflict of interest regrading this article.
: The study was approved by the ethics committe of every paticipating institution and the Spanish Food and Drug Agency.
: Every patient provided written consent before being included in this trial.
